AUDREY APPEL: Open Payments
NPI 1629756044 · ABERDEEN, SD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,664 in 81 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $103 · 2025 $1,664
Food & beverage: $1,608Education: $56
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 16 | $306 |
| AstraZeneca Pharmaceuticals LP | 11 | $251 |
| Takeda Pharmaceuticals U.S.A., Inc. | 12 | $231 |
| Verona Pharma, Inc. | 5 | $111 |
| CSL Behring | 6 | $108 |
| Viatris Specialty LLC | 5 | $98 |
| Insmed, Inc. | 4 | $79 |
| Grifols USA, LLC | 3 | $64 |
| BioCryst US Sales Co., LLC | 3 | $60 |
| Amgen Inc. | 3 | $59 |
Products named: DUPIXENT, GLASSIA, TEZSPIRE, Ohtuvayre, BREZTRI, YUPELRI, CUVITRU, Arikayce.
Industry payments across SD — which companies pay providers there.
